RecruitingHCCHepatocellular Carcinoma
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
Eligible age
18+ yrs
Accepts
All genders
Locations
2 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The study will be conducted at the following locations: 1. UT Southwestern Medical Center 2. Parkland Health and Hospital System 3. University of Michigan Investigators will prospectively compare the performance of dynamic contrast enhanced abbreviated MRI (AMRI) and contrast-enhanced ultrasound for early-stage HCC detection in patients with indeterminate liver nodules.
Sponsor: University of Texas Southwestern Medical Center
You may qualify if…
- ✓ Child A or B cirrhosis from any etiology with at least one ILN on 4-phase CT, contrast- enhanced MRI, or contrast enhanced US but without HCC at baseline.
- ✓ Adults 18 years old and above
You may not qualify if…
- ✕ Patients post liver transplantation
- ✕ Patients with concurrent or prior HCC (LR-5 or biopsy proven)
- ✕ other liver cancer including cholangiocarcinoma
- ✕ Patients with any active extra-hepatic malignancy
- ✕ Patients with significant comorbidity and limited life expectancy, e.g., stage D congestive heart failure, in whom surveillance is not warranted are also excluded given unlikely clinical benefit
- ✕ Patients with contraindication to contrast-enhanced MRI or CEUS, including implanted medical devices that are considered MR unsafe and severe claustrophobia
Where it's recruiting
Source: ClinicalTrials.gov · NCT06184152 · last updated 2026-07-02